Biomea Fusion, Inc. (BMEA) stock
BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.56−0.05 (-7.89%)
Close on Nov 12, 2026Market cap $40.79MP/E –Yield –
Biomea Fusion operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Biomea Fusion's operating cash flow for the twelve months ending Sep 30, 2026 was -$44.07M. For fiscal 2025 it was -$70.37M. The highest annual figure on record is -$1.28M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$70.37M | – |
| FY2024 | Dec 31, 2024 | -$119.89M | – |
| FY2023 | Dec 31, 2023 | -$96.59M | – |
| FY2022 | Dec 31, 2022 | -$62.42M | – |
| FY2021 | Dec 31, 2021 | -$35.44M | – |
| FY2020 | Dec 31, 2020 | -$4.46M | – |
| FY2019 | Dec 31, 2019 | -$1.28M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$8.43M | – |
| Q2 FY2026 | Jun 30, 2026 | -$10.03M | – |
| Q1 FY2026 | Mar 31, 2026 | -$11.67M | – |
| Q4 FY2025 | Dec 31, 2025 | -$13.94M | – |
| Q3 FY2025 | Sep 30, 2025 | -$11.55M | – |
| Q2 FY2025 | Jun 30, 2025 | -$19.21M | – |
| Q1 FY2025 | Mar 31, 2025 | -$25.67M | – |
| Q4 FY2024 | Dec 31, 2024 | -$30.00M | – |
| Q3 FY2024 | Sep 30, 2024 | -$25.22M | – |
| Q2 FY2024 | Jun 30, 2024 | -$32.64M | – |
| Q1 FY2024 | Mar 31, 2024 | -$32.03M | – |
| Q4 FY2023 | Dec 31, 2023 | -$22.84M | – |
| Q3 FY2023 | Sep 30, 2023 | -$23.90M | – |
| Q2 FY2023 | Jun 30, 2023 | -$25.81M | – |
| Q1 FY2023 | Mar 31, 2023 | -$24.04M | – |
| Q4 FY2022 | Dec 31, 2022 | -$20.20M | – |
| Q3 FY2022 | Sep 30, 2022 | -$16.80M | – |
| Q2 FY2022 | Jun 30, 2022 | -$15.43M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.99M | – |
| Q4 FY2021 | Dec 31, 2021 | -$15.90M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.99M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.48M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.08M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.74M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.10M | – |
| Q2 FY2020 | Jun 30, 2020 | -$369.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$252.00K | – |
See a number that looks wrong?